News

Aurora Cannabis posted mixed Q1 FY2026 results, facing sales pressure, covenant issues, and looming German regulatory risks.
If you invested in Canadian cannabis stocks just after legalization in 2018, at the height of investor fervor, you are likely ...
Canopy Growth (CGC), Cronos Group (CRON) and Trulieve Cannabis (TCNNF) after reports that U.S. President Donald Trump may ...
Shares of major cannabis companies are trading higher Monday morning. The stocks are soaring following a WSJ report that ...
To say Aurora Cannabis (NASDAQ: ACB) has faced some challenges over the years would be a huge understatement. The once-leading cannabis producer in the Canadian marijuana industry is now a shell ...
U.S. President Donald Trump’s administration is looking to reclassify marijuana as a less dangerous drug, a shift that could ...
With a share price down 99.5% from its early 2019 highs, $225 million in sales, and $818 million in annual losses, on the surface at least, Canadian marijuana stock Aurora Cannabis (ACB) stock ...
Should you buy Aurora Cannabis' stock today? Although Aurora is getting closer to adjusted EBITDA profitability, its net loss was still CA$51.9 million in Q1.
The Aurora City Council on Monday night gave preliminary approval, by an 8-2 vote, to cannabis delivery in Colorado’s third-largest city.
Even a skeptic will be forced to admit that Aurora Cannabis seems to be experiencing mounting momentum. The cannabis company's net revenue jumped 30% year over year, to 63.4 million in Canadian ...
Aurora Cannabis (ACB) announces the launch of Whistler Cannabis Co. in Australia. As one of Canada’s original cannabis brands, with a proud ...